Rhenman & Partners Asset Management AB as of Sept. 30, 2017
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 94 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 4.9 | $38M | 3.0M | 12.68 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $27M | 180k | 152.04 | |
| Exelixis (EXEL) | 3.2 | $25M | 1.1M | 24.23 | |
| Abiomed | 3.0 | $24M | 140k | 168.60 | |
| Alexion Pharmaceuticals | 3.0 | $23M | 165k | 140.29 | |
| Celgene Corporation | 2.8 | $22M | 152k | 145.82 | |
| Glaukos (GKOS) | 2.7 | $21M | 648k | 33.00 | |
| Nektar Therapeutics (NKTR) | 2.6 | $21M | 866k | 24.00 | |
| Allergan | 2.6 | $21M | 100k | 204.95 | |
| Adamas Pharmaceuticals | 2.5 | $19M | 915k | 21.17 | |
| Intra Cellular Therapies (ITCI) | 2.4 | $19M | 1.2M | 15.78 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $17M | 180k | 93.07 | |
| UnitedHealth (UNH) | 2.1 | $17M | 85k | 195.85 | |
| Medtronic (MDT) | 2.1 | $17M | 214k | 77.77 | |
| Portola Pharmaceuticals | 2.0 | $16M | 297k | 54.03 | |
| Esperion Therapeutics (ESPR) | 2.0 | $16M | 312k | 50.12 | |
| Express Scripts Holding | 2.0 | $16M | 245k | 63.32 | |
| Arena Pharmaceuticals | 1.9 | $15M | 570k | 25.50 | |
| Incyte Corporation (INCY) | 1.7 | $13M | 115k | 116.74 | |
| Novocure Ltd ord (NVCR) | 1.7 | $13M | 667k | 19.85 | |
| Gilead Sciences (GILD) | 1.6 | $13M | 156k | 81.02 | |
| Jazz Pharmaceuticals (JAZZ) | 1.6 | $12M | 85k | 146.25 | |
| Abbvie (ABBV) | 1.6 | $12M | 140k | 88.86 | |
| Nevro (NVRO) | 1.5 | $12M | 130k | 90.88 | |
| Centene Corporation (CNC) | 1.4 | $11M | 110k | 96.77 | |
| Anthem (ELV) | 1.3 | $10M | 55k | 189.87 | |
| Bristol Myers Squibb (BMY) | 1.3 | $10M | 161k | 63.74 | |
| CIGNA Corporation | 1.3 | $10M | 55k | 186.95 | |
| Humana (HUM) | 1.3 | $10M | 41k | 243.63 | |
| Regeneron Pharmaceuticals (REGN) | 1.3 | $9.8M | 22k | 447.14 | |
| Aetna | 1.3 | $9.9M | 62k | 159.02 | |
| CVS Caremark Corporation (CVS) | 1.2 | $9.8M | 120k | 81.32 | |
| Eli Lilly & Co. (LLY) | 1.2 | $9.4M | 110k | 85.54 | |
| Edwards Lifesciences (EW) | 1.1 | $8.7M | 80k | 109.31 | |
| Abbott Laboratories (ABT) | 1.1 | $8.3M | 155k | 53.36 | |
| Boston Scientific Corporation (BSX) | 1.0 | $8.2M | 281k | 29.17 | |
| Dynavax Technologies (DVAX) | 1.0 | $8.1M | 375k | 21.50 | |
| Array BioPharma | 1.0 | $8.0M | 650k | 12.30 | |
| Fibrogen (FGEN) | 1.0 | $7.8M | 146k | 53.80 | |
| Alkermes (ALKS) | 0.9 | $7.4M | 145k | 50.84 | |
| Neurocrine Biosciences (NBIX) | 0.9 | $7.0M | 115k | 61.28 | |
| Immunomedics | 0.9 | $7.0M | 500k | 13.98 | |
| Biogen Idec (BIIB) | 0.9 | $6.9M | 22k | 313.14 | |
| Loxo Oncology | 0.9 | $6.9M | 75k | 92.12 | |
| Revance Therapeutics (RVNC) | 0.9 | $6.8M | 246k | 27.55 | |
| AmerisourceBergen (COR) | 0.8 | $6.6M | 80k | 82.75 | |
| Endologix | 0.8 | $6.7M | 1.5M | 4.46 | |
| Livanova Plc Ord (LIVN) | 0.8 | $6.7M | 95k | 70.06 | |
| Sanofi-Aventis SA (SNY) | 0.8 | $6.5M | 130k | 49.79 | |
| Myokardia | 0.8 | $6.5M | 151k | 42.85 | |
| Rigel Pharmaceuticals (RIGL) | 0.8 | $6.0M | 2.4M | 2.54 | |
| Dex (DXCM) | 0.8 | $5.9M | 120k | 48.92 | |
| Aerie Pharmaceuticals | 0.8 | $5.9M | 121k | 48.60 | |
| Merck & Co (MRK) | 0.7 | $5.8M | 90k | 64.03 | |
| Xencor (XNCR) | 0.7 | $5.7M | 250k | 22.92 | |
| Universal Health Services (UHS) | 0.7 | $5.5M | 50k | 110.94 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $5.5M | 711k | 7.75 | |
| Walgreen Boots Alliance (WBA) | 0.7 | $5.4M | 70k | 77.21 | |
| Ultragenyx Pharmaceutical (RARE) | 0.7 | $5.3M | 100k | 53.26 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $5.0M | 43k | 117.50 | |
| Epizyme | 0.6 | $4.5M | 236k | 19.05 | |
| Juno Therapeutics | 0.6 | $4.5M | 100k | 44.86 | |
| Omnicell (OMCL) | 0.5 | $4.1M | 80k | 51.05 | |
| Macrogenics (MGNX) | 0.5 | $4.1M | 222k | 18.48 | |
| Rite Aid Corporation | 0.5 | $4.0M | 2.0M | 1.96 | |
| Hca Holdings (HCA) | 0.5 | $4.0M | 50k | 79.60 | |
| Novo Nordisk A/S (NVO) | 0.5 | $3.9M | 80k | 48.15 | |
| Achillion Pharmaceuticals | 0.5 | $3.8M | 850k | 4.49 | |
| Radius Health | 0.4 | $3.5M | 90k | 38.56 | |
| Sage Therapeutics (SAGE) | 0.4 | $3.1M | 50k | 62.30 | |
| Keryx Biopharmaceuticals | 0.4 | $2.8M | 400k | 7.10 | |
| Dermira | 0.3 | $2.7M | 100k | 27.00 | |
| Coherus Biosciences (CHRS) | 0.3 | $2.4M | 180k | 13.35 | |
| Intercept Pharmaceuticals In | 0.3 | $2.3M | 40k | 58.05 | |
| Chimerix (CMRX) | 0.3 | $2.1M | 400k | 5.25 | |
| Bioverativ Inc Com equity | 0.2 | $2.0M | 35k | 57.06 | |
| Ra Pharmaceuticals | 0.2 | $1.7M | 120k | 14.60 | |
| STAAR Surgical Company (STAA) | 0.1 | $1.1M | 90k | 12.46 | |
| Newlink Genetics Corporation | 0.1 | $1.0M | 100k | 10.18 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $1.0M | 15k | 66.73 | |
| Regulus Therapeutics | 0.1 | $725k | 580k | 1.25 | |
| JPMorgan Chase & Co. (JPM) | 0.1 | $539k | 5.6k | 95.55 | |
| Halliburton Company (HAL) | 0.1 | $513k | 11k | 46.03 | |
| Adverum Biotechnologies | 0.1 | $562k | 154k | 3.65 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $467k | 5.7k | 81.99 | |
| Wells Fargo & Company (WFC) | 0.1 | $477k | 8.7k | 55.13 | |
| Janus Capital conv | 0.1 | $472k | 14k | 34.82 | |
| Microsoft Corporation (MSFT) | 0.1 | $357k | 4.8k | 74.48 | |
| Pfizer (PFE) | 0.1 | $372k | 10k | 35.69 | |
| Symantec Corporation | 0.0 | $307k | 9.4k | 32.80 | |
| Qualcomm (QCOM) | 0.0 | $278k | 5.4k | 51.79 | |
| Ford Motor Company (F) | 0.0 | $340k | 28k | 11.97 | |
| Anheuser-Busch InBev NV (BUD) | 0.0 | $335k | 2.8k | 119.39 | |
| International Business Machines (IBM) | 0.0 | $256k | 1.8k | 144.96 |
